280 related articles for article (PubMed ID: 33988858)
1. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
Napolitano M; Fabbrocini G; Patruno C
Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
[No Abstract] [Full Text] [Related]
2. Recall dermatitis at patch test sites in an atopic dermatitis patient treated with dupilumab.
Collantes-Rodríguez C; Jiménez-Gallo D; Ossorio-García L; Villegas-Romero I; Linares-Barrios M
Contact Dermatitis; 2019 Jan; 80(1):69-70. PubMed ID: 30334260
[No Abstract] [Full Text] [Related]
3. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review.
Raffi J; Suresh R; Botto N; Murase JE
J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940
[TBL] [Abstract][Full Text] [Related]
4. Recalcitrant atopic dermatitis due to allergy to Compositae.
Wintzen M; Donker AS; van Zuuren EJ
Contact Dermatitis; 2003 Feb; 48(2):87-8. PubMed ID: 12694211
[TBL] [Abstract][Full Text] [Related]
5. Effects of dupilumab treatment on patch test reactions: A retrospective evaluation.
de Wijs LEM; van der Waa JD; Nijsten T; Silverberg JI; Kunkeler ACM; Hijnen DJ
Clin Exp Allergy; 2021 Jul; 51(7):959-967. PubMed ID: 33960047
[No Abstract] [Full Text] [Related]
6. Compositae-associated allergic contact dermatitis from bisabolol.
Jacob SE; Matiz C; Herro EM
Dermatitis; 2011; 22(2):102-5. PubMed ID: 21504695
[TBL] [Abstract][Full Text] [Related]
7. Sensitization patterns in Compositae-allergic patients with current or past atopic dermatitis.
Paulsen E; Andersen KE
Contact Dermatitis; 2013 May; 68(5):277-85. PubMed ID: 23601063
[TBL] [Abstract][Full Text] [Related]
8. Multicentre patch testing with compositae mix by the Swedish Contact Dermatitis Research Group.
Isaksson M; Hansson C; Inerot A; Lidén C; Matura M; Stenberg B; Möller H; Bruze M;
Acta Derm Venereol; 2011 May; 91(3):295-8. PubMed ID: 21365173
[TBL] [Abstract][Full Text] [Related]
9. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema.
Crepy MN; Nosbaum A; Bensefa-Colas L
Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059
[No Abstract] [Full Text] [Related]
10. Sesquiterpene lactone dermatitis in the young: is atopy a risk factor?
Paulsen E; Otkjaer A; Andersen KE
Contact Dermatitis; 2008 Jul; 59(1):1-6. PubMed ID: 18598305
[TBL] [Abstract][Full Text] [Related]
11. Allergic contact dermatitis to Compositae: An Australian case series.
Punchihewa N; Palmer A; Nixon R
Contact Dermatitis; 2022 Oct; 87(4):356-362. PubMed ID: 35603484
[TBL] [Abstract][Full Text] [Related]
12. Occupational contact dermatitis to Tanacetum cinerariifolium without sensitivity to sesquiterpene lactone mix or Compositae mix.
Rajagopalan AK; Rajagopalan B
Australas J Dermatol; 2024 May; 65(3):295-296. PubMed ID: 38429871
[No Abstract] [Full Text] [Related]
13. Effect of dupilumab on allergic contact dermatitis and patch testing.
Jo CE; Mufti A; Sachdeva M; Pratt M; Yeung J
J Am Acad Dermatol; 2021 Jun; 84(6):1772-1776. PubMed ID: 33617912
[No Abstract] [Full Text] [Related]
14. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
Yamane MLM; Belsito DV; Glass LRD
Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
[TBL] [Abstract][Full Text] [Related]
15. A retrospective review of dupilumab for atopic dermatitis patients with allergic contact dermatitis.
Chipalkatti N; Lee N; Zancanaro P; Dumont N; Kachuk C; Rosmarin D
J Am Acad Dermatol; 2019 Apr; 80(4):1166-1167. PubMed ID: 30630024
[No Abstract] [Full Text] [Related]
16. Facial and neck erythema associated with dupilumab treatment: A systematic review.
Jo CE; Finstad A; Georgakopoulos JR; Piguet V; Yeung J; Drucker AM
J Am Acad Dermatol; 2021 May; 84(5):1339-1347. PubMed ID: 33428978
[TBL] [Abstract][Full Text] [Related]
17. Contact allergy to Compositae plants in patients with atopic dermatitis.
Jovanović M; Poljacki M; Duran V; Vujanović L; Sente R; Stojanović S
Med Pregl; 2004; 57(5-6):209-18. PubMed ID: 15503788
[TBL] [Abstract][Full Text] [Related]
18. Screening for Compositae contact sensitization with sesquiterpene lactones and Compositae mix 2.5% pet.
Paulsen E; Andersen KE
Contact Dermatitis; 2019 Nov; 81(5):368-373. PubMed ID: 31265134
[TBL] [Abstract][Full Text] [Related]
19. Frequency of contact allergy to Compositae extracts in patients with atopic dermatitis.
Nettis E; Giordano D; Soccio Al; Ferrannini A; Tursi A
Contact Dermatitis; 2002 Sep; 47(3):169-70. PubMed ID: 12492554
[No Abstract] [Full Text] [Related]
20. Screening for Compositae sensitization with pure allergens: implications of molecular structure, strength of reaction, and time of testing.
Paulsen E; Andersen KE
Contact Dermatitis; 2011 Feb; 64(2):96-103. PubMed ID: 21138444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
